KuartisMED Medical Research, founded in 2012 and headquartered in Turkey, is strategically positioned in the Biotechnology and Medical Devices industries. With a commendable mission statement encapsulated in their slogan, "Developing innovative solutions for the well-being of newborns," the startup focuses on designing, developing, and manufacturing smart and safe medical products aimed at enhancing healthcare outcomes for newborns.
The company successfully attracted a $1.80M Seed Round investment on 28 November 2022, showcasing strong investor confidence. Among the notable investors are CVentures, Arya Women's Investment Platform, Growth Circuit, and the Turkey Development Fund. This diverse group of backers demonstrates significant interest from both gender-focused and technology-driven funds, potentially promising broad market penetration and impactful industry innovations.